US Patent Issued to Children's Medical Center on June 16 for "FGF21 compositions for treatment or prevention of neovascularization of the eye and methods therefor" (Massachusetts Inventors)

ALEXANDRIA, Va., June 16 -- United States Patent no. 12,653,863, issued on June 16, was assigned to Children's Medical Center Corp. (Boston).

"FGF21 compositions for treatment or prevention of neovascularization of the eye and methods therefor" was invented by Lois Smith (West Newton, Mass.) and Zhongjie Fu (Brookline, Mass.).

According to the abstract* released by the U.S. Patent & Trademark Office: "The instant disclosure provides methods and compositions related to discovery of a long-acting FGF21 as a therapeutic target for treatment or prevention of neovascular eye diseases or disorders that are characterized by angiogenesis, or of vascular diseases of the eye. Therapeutic and/or prophylactic uses and compositions of long-acting FGF2...